Attached files

file filename
8-K - 8-K - AMERICAN SCIENCE & ENGINEERING, INC.a11-32426_38k.htm

EXHIBIT 99.1

 

GRAPHIC

FOR IMMEDIATE RELEASE

 

 

AMERICAN SCIENCE AND ENGINEERING, INC.

REPORTS THIRD QUARTER FISCAL YEAR 2012 RESULTS AND

DECLARES QUARTERLY DIVIDEND

 

BILLERICA, Mass. — February 9, 2012American Science and Engineering, Inc. (“AS&E”) (NASDAQ: ASEI), a leading worldwide supplier of innovative X-ray inspection solutions, today reported its financial results for the third quarter of fiscal year 2012 ended December 31, 2011. The Company reported revenues of $57,907,000 as compared with revenues of $76,588,000 for the third quarter of fiscal year 2011, net income of $7,535,000 as compared with net income of $11,782,000 for the third quarter of fiscal year 2011, and earnings per share of $0.84 as compared with earnings per share of $1.28 for the third quarter of fiscal year 2011.

 

For the first nine months of fiscal year 2012 ended December 31, 2011, the Company reported revenues of $163,788,000 compared with record revenues of $210,868,000 for the same period in the prior fiscal year, net income of $20,079,000 compared with record net income of $33,252,000 for the same period in the prior fiscal year, and earnings per share of $2.18 compared with record earnings per share of $3.60 for the prior fiscal year.

 

The Company reported $55,813,000 in bookings for the third quarter of fiscal year 2012 as compared with bookings of $63,578,000 for the third quarter of the prior fiscal year. For the first nine months of fiscal year 2012 the Company reported bookings of $157,617,000 as compared with bookings of $256,440,000 for the first nine months of the prior fiscal year.  Backlog as of December 31, 2011 was $209,057,000 as compared with $241,301,000 at December 31, 2010.

 

In accordance with the previously announced dividend program, the Company is declaring a quarterly cash dividend of $0.50 per share, payable on March 5, 2012 to the holders of record at the close of business on February 21, 2012.

 

“We are focused on improving results through the continued expansion of our international business and the introduction of new, innovative products and services,” said Anthony Fabiano, AS&E’s President and CEO.  “Global economic uncertainties continue to cause order variability, but our sales team is making progress penetrating new targeted markets with solid growth potential which continues to diversify our customer base.  Cargo bookings in the quarter were led by orders for Z Portal® systems from key customers for critical infrastructure security, and the first order for the high-throughput, high-energy SentryTM Portal in the Middle East.  The Z Backscatter Van (ZBV) continues to spark interest in new arenas with over 20 systems booked in the quarter from international clients — including orders from customers in the Middle East, Africa, Latin America, Europe and Asia.”

 

Fabiano continued, “We remain committed to aggressively pursuing our strategy for growth by increasing our year-over-year investment in R&D — up 11% — to leverage innovative technologies in development into high-growth proprietary products. Finally, our confidence in our business has allowed us to continue to provide a $0.50 per share quarterly dividend to our shareholders.”

 

As previously announced, Anthony Fabiano, AS&E’s President and Chief Executive Officer, and Ken Galaznik, AS&E’s Senior Vice President, Chief Financial Officer, Treasurer and Clerk, will host the conference call on Thursday, February 9, 2012 at 4:30 pm ET to discuss the results and respond to questions. To participate in the conference call, please dial 1-866-543-6403 at least 10 minutes prior to its starting time. For international participants, dial +1 617-213-8896. Please tell the operator the confirmation code: 73252059.  You will be placed on hold until the conference call is ready to begin.

 

An audio replay of the teleconference will be available, in its entirety, starting Thursday, February 9th at 7:30 p.m. ET for a 48-hour period by dialing 1-888-286-8010. Internationally, please dial +1 617-801-6888. The conference identification number is 74399069. The replay will also be available at www.as-e.com in the Investor Information section following the conference.

 

About AS&E

 

American Science and Engineering, Inc. (AS&E) is a leading worldwide supplier of innovative X-ray inspection systems. With over 50 years of experience in developing advanced X-ray security systems, the Company’s product line utilizes a combination of technologies, including patented Z Backscatter technology, Radioactive Threat Detection (RTD), high energy transmission and dual

 



 

energy transmission X-ray. These technologies offer superior X-ray threat detection for plastic explosives, plastic weapons, liquid explosives, dirty bombs and nuclear devices. AS&E’s complete range of products include cargo inspection systems for port and border security, baggage screening systems for facility and aviation security, and personnel and passenger screening systems. AS&E® systems protect high-threat facilities and help combat terrorism, trade fraud, drug smuggling, weapon smuggling, illegal immigration, and people smuggling. AS&E customers include leading government agencies, border authorities, military bases, airports and corporations worldwide, including the U.S. Department of Homeland Security (DHS), U.S. Department of Defense (DoD), U.S. Customs and Border Protection (CBP), North Atlantic Treaty Organization (NATO),  and Abu Dhabi Customs. For more information on AS&E products and technologies, please visit www.as-e.com

 

Investor Relations Contact:

Annemarie Sadowski

American Science and Engineering, Inc.

asadowski@as-e.com

978-262-8828

 

Safe Harbor Statement: The foregoing press release contains statements concerning AS&E’s financial performance, markets and business operations that may be considered “forward-looking” under applicable securities laws.  AS&E wishes to caution readers of this press release that actual results might differ materially from those projected in any forward-looking statements. Factors which might cause actual results to differ materially from those projected in the forward-looking statements contained herein include the following: significant reductions, delays or cancellations (in full or in part) in procurements of the Company’s systems by the United States and other governments; disruption in the supply of any source component incorporated into AS&E’s products; litigation seeking to restrict the use of intellectual property used by the Company; limitations under certain laws on the Company’s ability to protect its own intellectual property; potential product liability claims against the Company; global political trends and events which affect public perception of the threat presented by drugs, explosives and other contraband; global economic developments and the ability of governments and private organizations to fund purchases of the Company’s products to address such threats; the potential insufficiency of Company resources, including human resources, capital, plant and equipment and management systems, to accommodate any future growth; technical problems and other delays that could impact new product development and the Company’s ability to adapt to changes in technology and customer requirements; competitive pressures; lengthy sales cycles both in United States government procurement and procurement abroad;  future delays in federal funding, the market price of the company’s stock prevailing from time to time, the nature of other investment opportunities presented to the company from time to time,  the company’s cash flows from operations and market and general economic conditions. These and certain other factors which might cause actual results to differ materially from those projected are detailed from time to time in AS&E’s periodic reports and registration statements filed with the Securities and Exchange Commission, which important factors are incorporated herein by reference. AS&E undertakes no obligation to update forward looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in future operating results, financial condition or business over time. Readers are further advised to review the “Risk Factors” set forth in the Company’s most recent Form 10-Q and Form 10-K,  which further detail and supplement the factors described in this Safe Harbor Statement.

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

December 31,
2011

 

December 31,
2010

 

December 31,
2011

 

December 31,
2010

 

Total net sales and contract revenues

 

$

57,907

 

$

76,588

 

$

163,788

 

$

210,868

 

 

 

 

 

 

 

 

 

 

 

Total cost of sales and contracts

 

31,462

 

41,884

 

88,320

 

112,508

 

Gross profit

 

26,445

 

34,704

 

75,468

 

98,360

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

9,091

 

10,774

 

26,728

 

31,584

 

Research and development

 

6,113

 

6,568

 

18,727

 

16,803

 

Total operating expenses

 

15,204

 

17,342

 

45,455

 

48,387

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

11,241

 

17,362

 

30,013

 

49,973

 

Interest and other income (expense)

 

176

 

(26

)

410

 

393

 

Income before provision for income taxes

 

11,417

 

17,336

 

30,423

 

50,366

 

Provision for income taxes

 

3,882

 

5,554

 

10,344

 

17,114

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

7,535

 

$

11,782

 

$

20,079

 

$

33,252

 

 

 

 

 

 

 

 

 

 

 

Income per share - Basic

 

$

0.84

 

$

1.31

 

$

2.21

 

$

3.69

 

Income per share - Diluted

 

$

0.84

 

$

1.28

 

$

2.18

 

$

3.60

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares - Basic

 

8,924

 

9,023

 

9,088

 

9,022

 

Weighted average shares - Diluted

 

9,009

 

9,236

 

9,193

 

9,225

 

 

The results of operations reported herein may not be indicative of future financial conditions or results of future operations.

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 (in thousands)

(unaudited)

 

 

 

December 31,
2011

 

March 31,
2011

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

29,495

 

$

60,144

 

Restricted cash and investments

 

12,846

 

20,398

 

Short-term investments, at fair value

 

174,052

 

110,141

 

Accounts receivable, net

 

27,044

 

37,180

 

Inventories

 

45,858

 

46,922

 

Other current assets

 

14,974

 

27,249

 

Total current assets

 

304,269

 

302,034

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

Building, equipment and leasehold improvements, net

 

18,041

 

18,559

 

Restricted cash and investments

 

784

 

9,062

 

Other assets

 

6,378

 

6,919

 

Total assets

 

$

329,472

 

$

336,574

 

 

 

 

 

 

 

Liabilities & Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

8,575

 

$

9,378

 

Customer deposits

 

17,401

 

9,193

 

Deferred revenue

 

15,668

 

16,924

 

Other current liabilities

 

20,210

 

25,930

 

Total current liabilities

 

61,854

 

61,425

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

Lease financing liability

 

4,751

 

5,755

 

Other non-current liabilities

 

2,643

 

3,314

 

Total liabilities

 

69,248

 

70,494

 

 

 

 

 

 

 

Total stockholders’ equity

 

260,224

 

266,080

 

Total liabilities and stockholders’ equity

 

$

329,472

 

$

336,574

 

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(in thousands)

 

 

 

For the Nine Months Ended

 

 

 

December 31,
2011

 

December 31,
2010

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

20,079

 

$

33,252

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

4,293

 

3,660

 

Provision for contracts, inventory and accounts receivable reserves

 

2,746

 

879

 

Amortization of bond premium

 

1,895

 

1,581

 

Deferred income taxes

 

1,559

 

(73

)

Other

 

(24

)

(122

)

Stock compensation expense

 

1,459

 

3,971

 

 

 

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

10,117

 

1,997

 

Unbilled costs and fees

 

13,497

 

(14,232

)

Inventories

 

(1,663

)

(5,519

)

Prepaid expenses and other assets

 

(2,212

)

986

 

Accounts payable

 

(803

)

1,491

 

Accrued income taxes

 

(52

)

(4,203

)

Customer deposits

 

8,208

 

(7,397

)

Deferred revenue

 

(1,922

)

2,527

 

Accrued expenses and other liabilities

 

(5,687

)

519

 

Net cash provided by operating activities

 

51,490

 

19,317

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of short-term investments

 

(217,785

)

(114,801

)

Proceeds from sales and maturities of short-term investments

 

151,937

 

149,222

 

Purchases of property and equipment

 

(3,751

)

(4,098

)

Net cash (used for) provided by investing activities

 

(69,599

)

30,323

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Decrease (increase) in restricted cash and investments

 

15,830

 

(28,485

)

Proceeds from exercise of stock options

 

2,835

 

3,739

 

Repurchase of shares of common stock

 

(20,050

)

(3,736

)

Repayment of leasehold financing

 

(990

)

(975

)

Payment of common stock dividend

 

(9,964

)

(8,129

)

Reduction of income taxes paid due to the tax benefit from employee stock option expense

 

(201

)

1,106

 

Net cash used for financing activities

 

(12,540

)

(36,480

)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

(30,649

)

13,160

 

Cash and cash equivalents at beginning of period

 

60,144

 

34,912

 

Cash and cash equivalents at end of period

 

$

29,495

 

$

48,072

 

 

####